Encuesta de situación de la atención farmacéutica oncohematológica en España

Martínez-Bautista, María José; Mangues-Bafalluy, Irene; Cajaraville-Ordoñana, Gerardo; Carreras-Soler, María Josep; Clopés-Estela, Ana; Moreno-Martínez, Estela.
Farm. hosp ; 43(6): 194-201, nov.-dic. 2019. tab
Artículo en Español | IBECS (España) | ID: ibc-187481

Documentos relacionados

  1. Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway.
  2. Chemotherapy Induces Cancer-Fighting B Cells.
  3. Synthesis of a Non-Symmetrical Disorazole C<sub>1</sub>-Analogue and Its Biological Activity.
  4. A Meta-analysis on the Effectiveness of Extracellular Vesicles as Nanosystems for Targeted Delivery of Anticancer Drugs.
  5. Microbes mediated immunogenic cell death in cancer immunotherapy.
  6. Determinants of cancer drug pricing and how to overcome the cancer premium.
  7. Development of small molecule inhibitors targeting RNA helicase DHX33 as anti-cancer agents.
  8. GEDEFO-SEFH management of antineoplastic extravasations survey results.
  9. DNN-PNN: A parallel deep neural network model to improve anticancer drug sensitivity.
  10. Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs.